wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38639698-6D144514-B475-431A-B967-8EB2CDE8E37C
Q38639698-6D144514-B475-431A-B967-8EB2CDE8E37C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38639698-6D144514-B475-431A-B967-8EB2CDE8E37C
Clinical applications and safety evaluation of the new CD19 specific T-cell engager antibody construct blinatumomab.
P2860
Q38639698-6D144514-B475-431A-B967-8EB2CDE8E37C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38639698-6D144514-B475-431A-B967-8EB2CDE8E37C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41bc56dfdfb77f602f01d5a65f9d85039d657fc6
P2860
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.